Cover Image
Market Research Report
Product code 
933057

Asia Pacific Immunochemistry Equipment Market to 2027 - Regional Analysis and Forecasts by Application, Product, End User, and Country

Published: | The Insight Partners | 213 Pages | Delivery time: 1-2 business days

Price

Back to Top
Asia Pacific Immunochemistry Equipment Market to 2027 - Regional Analysis and Forecasts by Application, Product, End User, and Country
Published: March 25, 2020
The Insight Partners
Content info: 213 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The immunochemistry equipment market in Asia Pacific is projected to reach US$ 795.05 million by 2027 from US$ 409.44 million in 2018. The market is anticipated to grow at a CAGR of 7.8% during 2019-2027.

The growth of the immunochemistry equipment market is primarily attributed to rising incidences of chronic and infectious diseases and increase in geriatric population. However, the limitations associated with immunohistochemistry equipment is likely to have a negative impact on its market growth. On the other hand, technological advancements in the region are likely to have a positive impact on the growth of the immunochemistry equipment market in Asia Pacific in the coming years.

Immunohistochemistry (IHC) refers to an important application of monoclonal and polyclonal antibody for tissue determination and distribution of antigens of a particular disease. The techniques are majorly used to detect several infectious diseases, such as dengue, hepatitis, human immunodeficiency virus (HIV). Chronic medical conditions such as obesity, cancer, diabetes, heart disease, and stroke are also considered to be the primary applications of immunohistochemistry equipment. Furthermore, surveillance and operational research on foodborne-diarrheal infections, healthcare-associated infections, respiratory diseases, and viral hepatitis have increased awareness about antibiotic resistant organisms.

According to the National Council on Aging, approximately 80% of adults suffer from at least one chronic disease. Immunohistochemistry techniques help in the quantification and diagnosis of chronic diseases accurately and reliably. The rising R&D expenditure in Asia Pacific is likely to propel the growth of the immunohistochemistry equipment market during the forecast period.

In 2018, the diagnostics segment accounted for the largest market share in the immunohistochemistry equipment market, by application. The growing benefits of immunohistochemistry techniques have prolonged its usage in diagnosing several chronic diseases. The application of the molecular diagnostics has allowed to treat the patients as per their genetic make-up, and also diagnosis through immunohistochemistry helps increase the use in precision medicine. Even the cost-effective nature of the immunochemistry techniques is driving significant growth across the region.

In 2018, the antibodies segment held the largest share of the immunochemistry equipment market, by product; it is also anticipated to dominate the market by 2027. Moreover, the reagent segment is anticipated to register the highest CAGR during the forecast period in the market as it forms an essential component of any reaction. It can be chosen as per the result to be obtained.

In 2018, the hospital & diagnostic laboratories segment held the most significant share of the immunochemistry equipment market, by end user. This segment is also anticipated to dominate the market by 2027. Besides, the segment is expected to grow at the fastest rate during the coming years due to the rise in the prevalence of infectious diseases and autoimmune disorders.

A few major secondary sources for immunochemistry equipment included in the report are Federation of AIDS Organizations (AFAO), American Heart Association (AHA), HIV and AIDS organization (AVERT), Centers for Disease Control and Prevention (CDC), Centers for Diabetes and Endocrinology (CDE), and Food and Drug Administration (FDA).

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia-Pacific immunochemistry market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the Asia-Pacific immunochemistry market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPRE00009804

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance

2. Asia-Pacific Immunochemistry Market- Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia-Pacific Immunochemistry Market - Market Landscape

  • 4.1 Overview
  • 4.2 Market Segmentation
    • 4.2.1 Asia-Pacific Immunochemistry Market - By Product
    • 4.2.2 Asia-Pacific Immunochemistry Market - By Application
    • 4.2.3 Asia-Pacific Immunochemistry Market - By End User
    • 4.2.4 Asia-Pacific Immunochemistry Market - By Country
  • 4.3 PEST Analysis
    • 4.3.1 Immunohistochemistry Market - Asia Pacific PEST Analysis

5. Asia-Pacific Immunochemistry Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rising Incidences of Chronic and Infectious Diseases in China
    • 5.1.2 Increasing R&D Investments by Biotechnology & Biopharmaceutical Companies in APAC
  • 5.2 Key Market Restraints
    • 5.2.1 Limitations Associated with Immunohistochemistry
  • 5.3 Key Market Opportunities
    • 5.3.1 Development Opportunities in Emerging Countries
  • 5.4 Future Trends
    • 5.4.1 Increasing Acceptance of Automation in Immunohistochemistry
  • 5.5 Impact Analysis

6. Immunochemistry Market - Asia-Pacific Analysis

  • 6.1 Asia-Pacific Immunochemistry Market Revenue Forecasts and Analysis
  • 6.2 Performance of Key Players

7. Asia-Pacific Immunochemistry Market Analysis - By Application

  • 7.1 Overview
  • 7.2 Asia-Pacific Immunochemistry Market, By Application, 2018 & 2027 (%)
  • 7.3 Asia-Pacific Immunochemistry Market Revenue and Forecasts to 2027, By Application (US$ Mn)
  • 7.4 Diagnostics
    • 7.4.1 Overview
    • 7.4.2 Asia-Pacific Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.3 Cancer
      • 7.4.3.1 Overview
      • 7.4.3.2 Asia-Pacific Cancer Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.4 Infectious Diseases
      • 7.4.4.1 Overview
      • 7.4.4.2 Asia-Pacific Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.5 Autoimmune Diseases
      • 7.4.5.1 Overview
      • 7.4.5.2 Asia-Pacific Autoimmune Diseases Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.6 Nephrological Diseases
      • 7.4.6.1 Overview
      • 7.4.6.2 Asia-Pacific Nephrological Diseases Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.5 Drug Testing
    • 7.5.1 Overview
    • 7.5.2 Asia-Pacific Drug Testing Market Revenue and Forecast to 2027 (US$ Mn)

8. Asia-Pacific Immunochemistry Market Analysis - By Product

  • 8.1 Overview
  • 8.2 Asia-Pacific Immunochemistry Market, By Product, 2018 & 2027 (%)
  • 8.3 Asia-Pacific Immunochemistry Market Revenue and Forecasts to 2027, By Product (US$ Mn)
    • 8.3.1 Asia-Pacific Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.3.2 Asia-Pacific Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 8.3.2.1 Asia-Pacific Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • 8.4 Antibodies Market
    • 8.4.1 Overview
    • 8.4.2 Asia-Pacific Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.4.3 Primary Antibodies
      • 8.4.3.1 Overview
      • 8.4.3.2 Asia-Pacific Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.4.4 Secondary Antibodies
      • 8.4.4.1 Overview
      • 8.4.4.2 Asia-Pacific Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.5 Equipment
    • 8.5.1 Overview
    • 8.5.2 Asia-Pacific Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.5.3 Slide Staining Systems
      • 8.5.3.1 Overview
      • 8.5.3.2 Asia-Pacific Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.5.4 Tissue Microarrays
      • 8.5.4.1 Overview
      • 8.5.4.2 Asia-Pacific Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.5.5 Slide Scanners
      • 8.5.5.1 Overview
      • 8.5.5.2 Asia-Pacific Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.5.6 Other Equipment
      • 8.5.6.1 Overview
      • 8.5.6.2 Asia-Pacific Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.6 Reagents
    • 8.6.1 Overview
    • 8.6.2 Asia-Pacific Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.6.3 Histological Stains
      • 8.6.3.1 Overview
      • 8.6.3.2 Asia-Pacific Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.6.4 Blocking & Fixation Reagents
      • 8.6.4.1 Overview
      • 8.6.4.2 Asia-Pacific Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.6.5 Chromogenic Substrates
      • 8.6.5.1 Overview
      • 8.6.5.2 Asia-Pacific Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.6.6 Stabilizers
      • 8.6.6.1 Overview
      • 8.6.6.2 Asia-Pacific Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.6.7 Proteolytic Enzymes
      • 8.6.7.1 Overview
      • 8.6.7.2 Asia-Pacific Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.6.8 Solvents
      • 8.6.8.1 Overview
      • 8.6.8.2 Asia-Pacific Solvents Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.7 Kits
    • 8.7.1 Overview
    • 8.7.2 Asia-Pacific Kits Market Revenue and Forecasts to 2027 (US$ Mn)

9. Asia-Pacific Immunochemistry Market Analysis - By End User

  • 9.1 Overview
  • 9.2 Asia-Pacific Immunochemistry Market, By End User, 2018 & 2027 (%)
  • 9.3 Asia-Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 9.4 Hospital & Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Asia-Pacific Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.5 Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Asia-Pacific Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.6 Others End Users
    • 9.6.1 Overview
    • 9.6.2 Asia-Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

10. Asia-Pacific Immunochemistry Market Revenue and Forecasts To 2027

  • 10.1 Asia Pacific Immunohistochemistry Market Revenue and Forecasts To 2027
  • 10.2 Asia Pacific Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
    • 10.2.1 Asia Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
      • 10.2.1.1 Asia Pacific Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 10.2.2 Asia Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.2.2.1 Asia Pacific Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 10.2.2.2 Asia Pacific Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 10.2.2.3 Asia Pacific Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 10.2.3 Asia Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.2.4 Asia Pacific Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)
    • 10.2.5 Japan Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.5.1 Japan Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.5.2 Japan Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
        • 10.2.5.2.1 Japan Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
      • 10.2.5.3 Japan Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
        • 10.2.5.3.1 Japan Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
        • 10.2.5.3.2 Japan Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
        • 10.2.5.3.3 Japan Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
      • 10.2.5.4 Japan Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.2.6 China Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.6.1 China Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.6.2 China Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
        • 10.2.6.2.1 China Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
      • 10.2.6.3 China Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
        • 10.2.6.3.1 China Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
        • 10.2.6.3.2 China Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
        • 10.2.6.3.3 China Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
      • 10.2.6.4 China Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.2.7 India Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.7.1 India Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.7.2 India Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
        • 10.2.7.2.1 India Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
      • 10.2.7.3 India Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
        • 10.2.7.3.1 India Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
        • 10.2.7.3.2 India Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
        • 10.2.7.3.3 India Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
      • 10.2.7.4 India Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.2.8 South Korea Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.8.1 South Korea Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.8.2 South Korea Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
        • 10.2.8.2.1 South Korea Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
      • 10.2.8.3 South Korea Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
        • 10.2.8.3.1 South Korea Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
        • 10.2.8.3.2 South Korea Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
        • 10.2.8.3.3 South Korea Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
      • 10.2.8.4 South Korea Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.2.9 Australia Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.9.1 Australia Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.9.2 Australia Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
        • 10.2.9.2.1 Australia Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
      • 10.2.9.3 Australia Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
        • 10.2.9.3.1 Australia Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
        • 10.2.9.3.2 Australia Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
        • 10.2.9.3.3 Australia Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
      • 10.2.9.4 Australia Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11. Immunochemistry Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies done by the companies in the Market, 2018 (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic developments
    • 11.4.1 Overview

12. Immunohistochemistry Market-Key Company Profiles

  • 12.1 Bio SB
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Financial Overview
    • 12.1.4 Product portfolio
    • 12.1.5 SWOT ANALYSIS
    • 12.1.6 Key Developments
  • 12.2 Cell Signaling Technology, Inc.
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Financial Overview
    • 12.2.4 Product portfolio
    • 12.2.5 SWOT ANALYSIS
    • 12.2.6 Key Developments
  • 12.3 F. Hoffmann-La Roche Ltd.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Financial Overview
    • 12.3.4 Product Portfolio
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Merck KGaA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Financial Overview
    • 12.4.4 Product Portfolio
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 PerkinElmer, Inc.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Financial Overview
    • 12.5.4 Product Portfolio
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Thermo Fisher Scientific, Inc.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Financial Overview
    • 12.6.4 Product Portfolio
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Abcam Plc.
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Financial Overview
    • 12.7.4 Product Portfolio
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Agilent Technologies, Inc.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Financial Overview
    • 12.8.4 Product Portfolio
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Bio-Rad Laboratories, Inc.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Financial Information
    • 12.9.4 Product Portfolio
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Danaher
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Financial Information
    • 12.10.4 Product Portfolio
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary Of Terms
  • 13.3 Methodology
    • 13.3.1 Coverage
    • 13.3.2 Secondary Research
    • 13.3.3 Primary Research

LIST OF TABLES

  • Table 1. R&D Investments by Major Biopharmaceutical Companies
  • Table 2. Asia-Pacific Immunochemistry Market Revenue and Forecasts To 2027, By Application (US$ Mn)
  • Table 3. Asia-Pacific Immunochemistry Market Revenue and Forecasts To 2027, By Product (US$ Mn)
  • Table 4. Asia-Pacific Antibodies Market Revenue And Forecasts To 2027, By Type (US$ Mn)
  • Table 5. Asia-Pacific Equipment Market Revenue And Forecasts To 2027, By Type (US$ Mn)
  • Table 6. Asia-Pacific Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 7. Asia-Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 8. Asia Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 9. Asia Pacific Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 10. Asia Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 11. Asia Pacific Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 12. Asia Pacific Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 13. Asia Pacific Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 14. Asia Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 15. Japan Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 16. Japan Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 17. Japan Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 18. Japan Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 19. Japan Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 20. Japan Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 21. Japan Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 22. China Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 23. China Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 24. China Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 25. China Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 26. China Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 27. China Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 28. China Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 29. India Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 30. India Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 31. India Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 32. India Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 33. India Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 34. India Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 35. India Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 36. South Korea Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 37. South Korea Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 38. South Korea Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 39. South Korea Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 40. South Korea Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 41. South Korea Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 42. South Korea Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 43. Australia Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 44. Australia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 45. Australia Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 46. Australia Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 47. Australia Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 48. Australia Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 49. Australia Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 50. Organic Developments Done By Companies
  • Table 51. Inorganic developments done by Companies
  • Table 52. Glossary Of Terms, Immunochemistry Market

LIST OF FIGURES

  • Figure 1. Asia-Pacific Immunochemistry Market Overview
  • Figure 2. Diagnostics Segment Held Largest Share of Application Segment in Immunochemistry Market
  • Figure 3. China is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 4. Asia-Pacific Immunochemistry Market- Leading Country Markets (US$ Mn)
  • Figure 5. Immunochemistry Market Segmentation
  • Figure 6. Immunohistochemistry Market - Asia Pacific Pest Analysis
  • Figure 7. Immunochemistry Market Impact Analysis of Drivers & Restraints
  • Figure 8. Asia-Pacific Immunochemistry Market - Revenue Forecasts And Analysis - 2018- 2027
  • Figure 9. Prominent Players in the Immunohistochemistry Market
  • Figure 10. Asia-Pacific Immunochemistry Market, By Application, 2018 & 2027 (%)
  • Figure 11. Asia-Pacific Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 12. Asia-Pacific Cancer Market Revenue and Forecasts To 2027 (US$ Mn)
  • Figure 13. Asia-Pacific Infectious Diseases Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 14. Asia-Pacific Autoimmune Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 15. Asia-Pacific Nephrological Diseases Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 16. Asia-Pacific Drug Testing Market Revenue and Forecasts To 2027 (US$ Mn)
  • Figure 17. Asia-Pacific Immunochemistry Market, By Product 2018 & 2027 (%)
  • Figure 18. Asia-Pacific Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 19. Asia-Pacific Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 20. Asia-Pacific Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 21. Asia-Pacific Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 22. Asia-Pacific Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 23. Asia-Pacific Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 24. Asia-Pacific Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 25. Asia-Pacific Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 26. Asia-Pacific Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 27. Asia-Pacific Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 28. Asia-Pacific Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 29. Asia-Pacific Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 30. Asia-Pacific Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 31. Asia-Pacific Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 32. Asia-Pacific Solvents Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 33. Asia-Pacific Kits Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 34. Asia-Pacific Immunochemistry Market, By End User, 2018 & 2027 (%)
  • Figure 35. Asia-Pacific Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 36. Asia-Pacific Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 37. Asia-Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 38. Asia Pacific Immunohistochemistry Market Overview, by Country (2018)
  • Figure 39. Asia Pacific Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 40. Asia Pacific Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 41. Japan Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 42. China Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 43. India Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 44. South Korea Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 45. Australia Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 46. Growth Strategies done by the companies in the Market, 2018 (%)